264 related articles for article (PubMed ID: 38474418)
1. A Review on the Role and Function of Cinnabarinic Acid, a "Forgotten" Metabolite of the Kynurenine Pathway.
Gawel K
Cells; 2024 Mar; 13(5):. PubMed ID: 38474418
[TBL] [Abstract][Full Text] [Related]
2. An expanding range of targets for kynurenine metabolites of tryptophan.
Stone TW; Stoy N; Darlington LG
Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
[TBL] [Abstract][Full Text] [Related]
3. Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.
Fazio F; Lionetto L; Curto M; Iacovelli L; Copeland CS; Neale SA; Bruno V; Battaglia G; Salt TE; Nicoletti F
Neuropharmacology; 2017 Jan; 112(Pt B):365-372. PubMed ID: 27342123
[TBL] [Abstract][Full Text] [Related]
4. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
Fukushima T; Umino M; Sakamoto T; Onozato M
Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
[TBL] [Abstract][Full Text] [Related]
5. Unstability of cinnabarinic acid, an endogenous metabolite of tryptophan, under situations mimicking physiological conditions.
Gómez-Piñeiro RJ; Dali M; Mansuy D; Boucher JL
Biochimie; 2022 Aug; 199():150-157. PubMed ID: 35469990
[TBL] [Abstract][Full Text] [Related]
6. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
7. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
Ciapała K; Mika J; Rojewska E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
[TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan metabolites and brain disorders.
Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
[TBL] [Abstract][Full Text] [Related]
10. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors.
Fazio F; Lionetto L; Molinaro G; Bertrand HO; Acher F; Ngomba RT; Notartomaso S; Curini M; Rosati O; Scarselli P; Di Marco R; Battaglia G; Bruno V; Simmaco M; Pin JP; Nicoletti F; Goudet C
Mol Pharmacol; 2012 May; 81(5):643-56. PubMed ID: 22311707
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.
Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR
Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802
[TBL] [Abstract][Full Text] [Related]
12. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S
Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237
[TBL] [Abstract][Full Text] [Related]
13. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
[TBL] [Abstract][Full Text] [Related]
14. Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.
Fukuyama K; Okada M
Br J Pharmacol; 2018 Nov; 175(22):4253-4265. PubMed ID: 30153331
[TBL] [Abstract][Full Text] [Related]
15. Dietary Kynurenine Pathway Metabolites-Source, Fate, and Chromatographic Determinations.
Sadok I; Jędruchniewicz K
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003492
[TBL] [Abstract][Full Text] [Related]
16. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.
Moroni F
Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
19. Kynurenines, neurodegeneration and Alzheimer's disease.
Kincses ZT; Toldi J; Vécsei L
J Cell Mol Med; 2010 Aug; 14(8):2045-54. PubMed ID: 20629991
[TBL] [Abstract][Full Text] [Related]
20. Central kynurenine pathway shift with age in women.
de Bie J; Guest J; Guillemin GJ; Grant R
J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
